The Antimicrobial Advisory Committee of the FDA met today, as anticipated, to decide whether it would recommend Molnupiravir, an oral antivirus drug, as a new treatment option for Covid-19. There are now voices, and although …
FDA Advisory Panel Endorses Merck’s COVID-19 Pill, But It Was A Close Vote
